(Q33383417)

English

Phase I trial of AEG35156 administered as a 7-day and 3-day continuous intravenous infusion in patients with advanced refractory cancer

scientific article

Statements

Phase I trial of AEG35156 administered as a 7-day and 3-day continuous intravenous infusion in patients with advanced refractory cancer (English)
23 February 2009
1660-1666

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit